Patient satisfaction with 6-month paliperidone palmitate versus other long-acting injectable antipsychotics

被引：0
|
作者：
Perez-Balaguer, A. [1 ]
Garcia del Castillo, I. [1 ]
Gomez-Esteban, B. [1 ]
Vicente-Burguillo, M. [1 ]
Vizcaino-Herrezuelo, H. [2 ]
Castelao-Almodovar, S. [2 ]
Arce de la Riva, A. [2 ]
Neira-Serrano, F. [3 ]
机构：
[1] El Escorial Hosp, Psychiat, Madrid, Spain
[2] Puerta Hierro Univ Hosp, Psychiat, Madrid, Spain
[3] Francisco Vitoria Univ, Stat, Madrid, Spain
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
10.1192/j.eurpsy.2024.1509
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV0909
引用
收藏
页码：S726 / S726
页数：1
相关论文
共 50 条
  • [21] Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
    Voss, Erica A.
    Ryan, Patrick B.
    Stang, Paul E.
    Hough, David
    Alphs, Larry
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2015, 30 (03) : 151 - 157
  • [22] Long-acting injectable versus oral antipsychotics for schizophrenia
    Munkholm, Klaus
    LANCET PSYCHIATRY, 2021, 8 (07): : 566 - 567
  • [23] EFFICACY AND TOLERABILITY OF LONG-ACTING INJECTABLE PALIPERIDONE PALMITATE IN THE TREATMENT OF DUAL PSYCHOSIS
    Vazquez Vazquez, J. M.
    Gonzalez-Rodriguez, A.
    Sanz Asin, P.
    Vicente Perellon, L.
    Lopez Garcia, F. J.
    Cruz Alonso, C.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [24] A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia
    Li, Huafang
    Rui, Qing
    Ning, Xiaoping
    Xu, Haiyan
    Gu, Niufan
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04): : 1002 - 1008
  • [25] Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?
    Ravenstijn, Paulien
    Samtani, Mahesh
    Russu, Alberto
    Hough, David
    Gopal, Srihari
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 36 (06) : 744 - 745
  • [26] Paliperidone Palmitate Long-Acting Injectable Given Intramuscularly in the Deltoid Versus the Gluteal Muscle Are They Therapeutically Equivalent?
    Yin, John
    Collier, Abby C.
    Barr, Alasdair M.
    Honer, William G.
    Procyshyn, Ric M.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (04) : 447 - 449
  • [27] Long-acting injectable antipsychotics: Diagnostics and patient profile
    Perez Gomez, L.
    Gonzalez Fernandez, A.
    Frias Ortiz, D. F.
    Al Shaban Rodriguez, O. W. Muquebil Ali
    Rodriguez Mercado, C. M.
    Jalon Urbina, M.
    Garcia Gonzalez, L.
    EUROPEAN PSYCHIATRY, 2016, 33 : S616 - S616
  • [28] Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study
    Giron-Hernandez, Cesar
    Han, Joong Hee
    Alberio, Roberta
    Singh, Arun
    Garcia-Portilla, Maria Paz
    Pompili, Maurizio
    Knight, R. Karl
    Richarz, Ute
    Gopal, Srihari
    Antunes, Jose
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 895 - 906
  • [29] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [30] COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE LONG -ACTING INJECTABLE VERSUS ORAL ANTIPSYCHOTICS FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA IN PERU
    Longaray, E.
    Guerrero, E.
    Aguirre, A.
    Hernandez, J.
    VALUE IN HEALTH, 2018, 21 : S185 - S185
12345